Icosavax lands $100M to take its virus-like particle vaccines into clinical trials,

Icosavax has drawn up clinical trial plans for its new type of vaccine in a strategy to commence tests of multiple programs, including a Covid-19 …, Icosavax has drawn up clinical trial plans for its new type of vaccine in a strategy to commence tests of multiple programs, including a Covid-19 …, Read More

Scroll to Top